Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer

Standard chemotherapy for advanced NSCLC has reached a therapeutic plateau. More effective strategies must be explored. The purpose of this study was to evaluate the role of metronomic chemotherapy combined with an angiogenesis inhibitor in non-small cell lung cancer (NSCLC). A total of 114 BALB/c n...

Descripción completa

Detalles Bibliográficos
Autores principales: WANG, RUI, QIN, SHUKUI, CHEN, YUQING, LI, YUMEI, CHEN, CHANGJIE, WANG, ZISHU, ZHENG, RONGSHENG, WU, QIONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583573/
https://www.ncbi.nlm.nih.gov/pubmed/22641525
http://dx.doi.org/10.3892/or.2012.1828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583573/
https://www.ncbi.nlm.nih.gov/pubmed/22641525
http://dx.doi.org/10.3892/or.2012.1828

Ejemplares similares